nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—coronary artery disease	0.397	0.591	CbGaD
Pentosan Polysulfate—FGF2—coronary artery disease	0.275	0.409	CbGaD
Pentosan Polysulfate—FGF1—artery—coronary artery disease	0.00385	0.211	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—coronary artery disease	0.00326	0.178	CbGeAlD
Pentosan Polysulfate—FGF1—cardiac ventricle—coronary artery disease	0.00216	0.118	CbGeAlD
Pentosan Polysulfate—FGF1—myocardium—coronary artery disease	0.00203	0.111	CbGeAlD
Pentosan Polysulfate—FGF2—heart—coronary artery disease	0.00191	0.105	CbGeAlD
Pentosan Polysulfate—FGF1—heart—coronary artery disease	0.00142	0.0778	CbGeAlD
Pentosan Polysulfate—FGF1—cardiovascular system—coronary artery disease	0.00134	0.0734	CbGeAlD
Pentosan Polysulfate—FGF1—cardiac atrium—coronary artery disease	0.00121	0.0665	CbGeAlD
Pentosan Polysulfate—FGF1—blood—coronary artery disease	0.00106	0.0581	CbGeAlD
Pentosan Polysulfate—Pruritus—Simvastatin—coronary artery disease	9.74e-05	0.000636	CcSEcCtD
Pentosan Polysulfate—Dizziness—Lovastatin—coronary artery disease	9.73e-05	0.000635	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Telmisartan—coronary artery disease	9.71e-05	0.000634	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Eplerenone—coronary artery disease	9.67e-05	0.000631	CcSEcCtD
Pentosan Polysulfate—Urticaria—Trandolapril—coronary artery disease	9.6e-05	0.000627	CcSEcCtD
Pentosan Polysulfate—Constipation—Perindopril—coronary artery disease	9.59e-05	0.000626	CcSEcCtD
Pentosan Polysulfate—Vomiting—Fenofibrate—coronary artery disease	9.59e-05	0.000626	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Losartan—coronary artery disease	9.58e-05	0.000625	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Valsartan—coronary artery disease	9.58e-05	0.000625	CcSEcCtD
Pentosan Polysulfate—Urticaria—Enalapril—coronary artery disease	9.56e-05	0.000624	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Trandolapril—coronary artery disease	9.56e-05	0.000624	CcSEcCtD
Pentosan Polysulfate—Dizziness—Ezetimibe—coronary artery disease	9.55e-05	0.000623	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Enalapril—coronary artery disease	9.52e-05	0.000621	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Captopril—coronary artery disease	9.52e-05	0.000621	CcSEcCtD
Pentosan Polysulfate—Insomnia—Losartan—coronary artery disease	9.51e-05	0.000621	CcSEcCtD
Pentosan Polysulfate—Rash—Fenofibrate—coronary artery disease	9.51e-05	0.000621	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Fenofibrate—coronary artery disease	9.5e-05	0.00062	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Furosemide—coronary artery disease	9.47e-05	0.000619	CcSEcCtD
Pentosan Polysulfate—Headache—Fenofibrate—coronary artery disease	9.44e-05	0.000617	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Losartan—coronary artery disease	9.44e-05	0.000616	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Captopril—coronary artery disease	9.44e-05	0.000616	CcSEcCtD
Pentosan Polysulfate—Urticaria—Telmisartan—coronary artery disease	9.43e-05	0.000616	CcSEcCtD
Pentosan Polysulfate—Vomiting—Clopidogrel—coronary artery disease	9.42e-05	0.000615	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Simvastatin—coronary artery disease	9.42e-05	0.000615	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Ramipril—coronary artery disease	9.41e-05	0.000614	CcSEcCtD
Pentosan Polysulfate—Myalgia—Ramipril—coronary artery disease	9.41e-05	0.000614	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Telmisartan—coronary artery disease	9.39e-05	0.000613	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Losartan—coronary artery disease	9.38e-05	0.000612	CcSEcCtD
Pentosan Polysulfate—Vomiting—Lovastatin—coronary artery disease	9.36e-05	0.000611	CcSEcCtD
Pentosan Polysulfate—Dizziness—Eplerenone—coronary artery disease	9.34e-05	0.00061	CcSEcCtD
Pentosan Polysulfate—Rash—Clopidogrel—coronary artery disease	9.34e-05	0.00061	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Clopidogrel—coronary artery disease	9.33e-05	0.000609	CcSEcCtD
Pentosan Polysulfate—Constipation—Furosemide—coronary artery disease	9.32e-05	0.000608	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Niacin—coronary artery disease	9.31e-05	0.000608	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Lisinopril—coronary artery disease	9.3e-05	0.000607	CcSEcCtD
Pentosan Polysulfate—Discomfort—Ramipril—coronary artery disease	9.29e-05	0.000607	CcSEcCtD
Pentosan Polysulfate—Headache—Clopidogrel—coronary artery disease	9.28e-05	0.000606	CcSEcCtD
Pentosan Polysulfate—Rash—Lovastatin—coronary artery disease	9.28e-05	0.000606	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Lovastatin—coronary artery disease	9.27e-05	0.000605	CcSEcCtD
Pentosan Polysulfate—Anaemia—Lisinopril—coronary artery disease	9.26e-05	0.000605	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Losartan—coronary artery disease	9.26e-05	0.000604	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Perindopril—coronary artery disease	9.24e-05	0.000603	CcSEcCtD
Pentosan Polysulfate—Headache—Lovastatin—coronary artery disease	9.22e-05	0.000602	CcSEcCtD
Pentosan Polysulfate—Pruritus—Valsartan—coronary artery disease	9.2e-05	0.000601	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Timolol—coronary artery disease	9.2e-05	0.0006	CcSEcCtD
Pentosan Polysulfate—Myalgia—Timolol—coronary artery disease	9.2e-05	0.0006	CcSEcCtD
Pentosan Polysulfate—Vomiting—Ezetimibe—coronary artery disease	9.18e-05	0.000599	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Pravastatin—coronary artery disease	9.17e-05	0.000599	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Perindopril—coronary artery disease	9.17e-05	0.000599	CcSEcCtD
Pentosan Polysulfate—Pruritus—Olmesartan—coronary artery disease	9.16e-05	0.000598	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Losartan—coronary artery disease	9.14e-05	0.000597	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Captopril—coronary artery disease	9.13e-05	0.000596	CcSEcCtD
Pentosan Polysulfate—Dizziness—Simvastatin—coronary artery disease	9.1e-05	0.000594	CcSEcCtD
Pentosan Polysulfate—Rash—Ezetimibe—coronary artery disease	9.1e-05	0.000594	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Ezetimibe—coronary artery disease	9.09e-05	0.000594	CcSEcCtD
Pentosan Polysulfate—Discomfort—Timolol—coronary artery disease	9.09e-05	0.000593	CcSEcCtD
Pentosan Polysulfate—Headache—Ezetimibe—coronary artery disease	9.04e-05	0.00059	CcSEcCtD
Pentosan Polysulfate—Malaise—Lisinopril—coronary artery disease	9.04e-05	0.00059	CcSEcCtD
Pentosan Polysulfate—Oedema—Ramipril—coronary artery disease	9.02e-05	0.000589	CcSEcCtD
Pentosan Polysulfate—Constipation—Losartan—coronary artery disease	8.99e-05	0.000587	CcSEcCtD
Pentosan Polysulfate—Vomiting—Eplerenone—coronary artery disease	8.98e-05	0.000587	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Furosemide—coronary artery disease	8.98e-05	0.000586	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Lisinopril—coronary artery disease	8.97e-05	0.000586	CcSEcCtD
Pentosan Polysulfate—Nausea—Fenofibrate—coronary artery disease	8.95e-05	0.000585	CcSEcCtD
Pentosan Polysulfate—Pruritus—Niacin—coronary artery disease	8.94e-05	0.000584	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Furosemide—coronary artery disease	8.91e-05	0.000582	CcSEcCtD
Pentosan Polysulfate—Rash—Eplerenone—coronary artery disease	8.91e-05	0.000582	CcSEcCtD
Pentosan Polysulfate—Urticaria—Perindopril—coronary artery disease	8.91e-05	0.000581	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Trandolapril—coronary artery disease	8.91e-05	0.000581	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Eplerenone—coronary artery disease	8.9e-05	0.000581	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Valsartan—coronary artery disease	8.9e-05	0.000581	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Enalapril—coronary artery disease	8.87e-05	0.000579	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Perindopril—coronary artery disease	8.86e-05	0.000579	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Olmesartan—coronary artery disease	8.85e-05	0.000578	CcSEcCtD
Pentosan Polysulfate—Headache—Eplerenone—coronary artery disease	8.85e-05	0.000578	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Ramipril—coronary artery disease	8.83e-05	0.000576	CcSEcCtD
Pentosan Polysulfate—Oedema—Timolol—coronary artery disease	8.82e-05	0.000576	CcSEcCtD
Pentosan Polysulfate—Pruritus—Pravastatin—coronary artery disease	8.81e-05	0.000575	CcSEcCtD
Pentosan Polysulfate—Nausea—Clopidogrel—coronary artery disease	8.8e-05	0.000575	CcSEcCtD
Pentosan Polysulfate—Infection—Timolol—coronary artery disease	8.76e-05	0.000572	CcSEcCtD
Pentosan Polysulfate—Vomiting—Simvastatin—coronary artery disease	8.75e-05	0.000572	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Telmisartan—coronary artery disease	8.75e-05	0.000571	CcSEcCtD
Pentosan Polysulfate—Nausea—Lovastatin—coronary artery disease	8.74e-05	0.000571	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Ramipril—coronary artery disease	8.72e-05	0.000569	CcSEcCtD
Pentosan Polysulfate—Rash—Simvastatin—coronary artery disease	8.68e-05	0.000567	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Simvastatin—coronary artery disease	8.67e-05	0.000566	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Losartan—coronary artery disease	8.67e-05	0.000566	CcSEcCtD
Pentosan Polysulfate—Urticaria—Furosemide—coronary artery disease	8.66e-05	0.000565	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Niacin—coronary artery disease	8.65e-05	0.000565	CcSEcCtD
Pentosan Polysulfate—Headache—Simvastatin—coronary artery disease	8.63e-05	0.000563	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Furosemide—coronary artery disease	8.62e-05	0.000562	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Losartan—coronary artery disease	8.6e-05	0.000561	CcSEcCtD
Pentosan Polysulfate—Dizziness—Valsartan—coronary artery disease	8.6e-05	0.000561	CcSEcCtD
Pentosan Polysulfate—Anorexia—Ramipril—coronary artery disease	8.6e-05	0.000561	CcSEcCtD
Pentosan Polysulfate—Nausea—Ezetimibe—coronary artery disease	8.58e-05	0.00056	CcSEcCtD
Pentosan Polysulfate—Dizziness—Olmesartan—coronary artery disease	8.56e-05	0.000559	CcSEcCtD
Pentosan Polysulfate—Pruritus—Trandolapril—coronary artery disease	8.55e-05	0.000558	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Lisinopril—coronary artery disease	8.53e-05	0.000557	CcSEcCtD
Pentosan Polysulfate—Myalgia—Lisinopril—coronary artery disease	8.53e-05	0.000557	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Timolol—coronary artery disease	8.52e-05	0.000556	CcSEcCtD
Pentosan Polysulfate—Pruritus—Enalapril—coronary artery disease	8.52e-05	0.000556	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Pravastatin—coronary artery disease	8.52e-05	0.000556	CcSEcCtD
Pentosan Polysulfate—Discomfort—Lisinopril—coronary artery disease	8.43e-05	0.00055	CcSEcCtD
Pentosan Polysulfate—Anorexia—Timolol—coronary artery disease	8.4e-05	0.000549	CcSEcCtD
Pentosan Polysulfate—Pruritus—Telmisartan—coronary artery disease	8.4e-05	0.000548	CcSEcCtD
Pentosan Polysulfate—Nausea—Eplerenone—coronary artery disease	8.39e-05	0.000548	CcSEcCtD
Pentosan Polysulfate—Dizziness—Niacin—coronary artery disease	8.36e-05	0.000546	CcSEcCtD
Pentosan Polysulfate—Urticaria—Losartan—coronary artery disease	8.35e-05	0.000545	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Losartan—coronary artery disease	8.31e-05	0.000543	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Trandolapril—coronary artery disease	8.27e-05	0.00054	CcSEcCtD
Pentosan Polysulfate—Vomiting—Valsartan—coronary artery disease	8.27e-05	0.00054	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Enalapril—coronary artery disease	8.24e-05	0.000538	CcSEcCtD
Pentosan Polysulfate—Dizziness—Pravastatin—coronary artery disease	8.23e-05	0.000537	CcSEcCtD
Pentosan Polysulfate—Vomiting—Olmesartan—coronary artery disease	8.23e-05	0.000537	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.22e-05	0.000536	CcSEcCtD
Pentosan Polysulfate—Rash—Valsartan—coronary artery disease	8.2e-05	0.000535	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Valsartan—coronary artery disease	8.19e-05	0.000535	CcSEcCtD
Pentosan Polysulfate—Nausea—Simvastatin—coronary artery disease	8.18e-05	0.000534	CcSEcCtD
Pentosan Polysulfate—Oedema—Lisinopril—coronary artery disease	8.18e-05	0.000534	CcSEcCtD
Pentosan Polysulfate—Pruritus—Captopril—coronary artery disease	8.17e-05	0.000533	CcSEcCtD
Pentosan Polysulfate—Rash—Olmesartan—coronary artery disease	8.16e-05	0.000533	CcSEcCtD
Pentosan Polysulfate—Insomnia—Ramipril—coronary artery disease	8.16e-05	0.000532	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Olmesartan—coronary artery disease	8.15e-05	0.000532	CcSEcCtD
Pentosan Polysulfate—Headache—Valsartan—coronary artery disease	8.15e-05	0.000532	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Telmisartan—coronary artery disease	8.13e-05	0.00053	CcSEcCtD
Pentosan Polysulfate—Infection—Lisinopril—coronary artery disease	8.12e-05	0.00053	CcSEcCtD
Pentosan Polysulfate—Headache—Olmesartan—coronary artery disease	8.11e-05	0.000529	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Ramipril—coronary artery disease	8.1e-05	0.000529	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Ramipril—coronary artery disease	8.04e-05	0.000525	CcSEcCtD
Pentosan Polysulfate—Vomiting—Niacin—coronary artery disease	8.04e-05	0.000525	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Timolol—coronary artery disease	8.03e-05	0.000524	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Furosemide—coronary artery disease	8.03e-05	0.000524	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Lisinopril—coronary artery disease	8.01e-05	0.000523	CcSEcCtD
Pentosan Polysulfate—Dizziness—Trandolapril—coronary artery disease	7.99e-05	0.000522	CcSEcCtD
Pentosan Polysulfate—Insomnia—Timolol—coronary artery disease	7.97e-05	0.000521	CcSEcCtD
Pentosan Polysulfate—Rash—Niacin—coronary artery disease	7.97e-05	0.00052	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Niacin—coronary artery disease	7.96e-05	0.00052	CcSEcCtD
Pentosan Polysulfate—Dizziness—Enalapril—coronary artery disease	7.96e-05	0.00052	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Ramipril—coronary artery disease	7.94e-05	0.000518	CcSEcCtD
Pentosan Polysulfate—Pruritus—Perindopril—coronary artery disease	7.93e-05	0.000518	CcSEcCtD
Pentosan Polysulfate—Headache—Niacin—coronary artery disease	7.92e-05	0.000517	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Timolol—coronary artery disease	7.92e-05	0.000517	CcSEcCtD
Pentosan Polysulfate—Vomiting—Pravastatin—coronary artery disease	7.91e-05	0.000517	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Lisinopril—coronary artery disease	7.91e-05	0.000516	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Captopril—coronary artery disease	7.9e-05	0.000516	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Timolol—coronary artery disease	7.86e-05	0.000513	CcSEcCtD
Pentosan Polysulfate—Dizziness—Telmisartan—coronary artery disease	7.85e-05	0.000513	CcSEcCtD
Pentosan Polysulfate—Rash—Pravastatin—coronary artery disease	7.85e-05	0.000512	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Pravastatin—coronary artery disease	7.84e-05	0.000512	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Ramipril—coronary artery disease	7.84e-05	0.000512	CcSEcCtD
Pentosan Polysulfate—Headache—Pravastatin—coronary artery disease	7.8e-05	0.000509	CcSEcCtD
Pentosan Polysulfate—Anorexia—Lisinopril—coronary artery disease	7.8e-05	0.000509	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Timolol—coronary artery disease	7.76e-05	0.000507	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Losartan—coronary artery disease	7.75e-05	0.000506	CcSEcCtD
Pentosan Polysulfate—Nausea—Valsartan—coronary artery disease	7.72e-05	0.000504	CcSEcCtD
Pentosan Polysulfate—Pruritus—Furosemide—coronary artery disease	7.71e-05	0.000503	CcSEcCtD
Pentosan Polysulfate—Constipation—Ramipril—coronary artery disease	7.71e-05	0.000503	CcSEcCtD
Pentosan Polysulfate—Nausea—Olmesartan—coronary artery disease	7.69e-05	0.000502	CcSEcCtD
Pentosan Polysulfate—Vomiting—Trandolapril—coronary artery disease	7.69e-05	0.000502	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Perindopril—coronary artery disease	7.67e-05	0.000501	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Timolol—coronary artery disease	7.66e-05	0.0005	CcSEcCtD
Pentosan Polysulfate—Vomiting—Enalapril—coronary artery disease	7.66e-05	0.0005	CcSEcCtD
Pentosan Polysulfate—Dizziness—Captopril—coronary artery disease	7.64e-05	0.000499	CcSEcCtD
Pentosan Polysulfate—Rash—Trandolapril—coronary artery disease	7.62e-05	0.000498	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Trandolapril—coronary artery disease	7.61e-05	0.000497	CcSEcCtD
Pentosan Polysulfate—Rash—Enalapril—coronary artery disease	7.59e-05	0.000496	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Enalapril—coronary artery disease	7.58e-05	0.000495	CcSEcCtD
Pentosan Polysulfate—Headache—Trandolapril—coronary artery disease	7.57e-05	0.000494	CcSEcCtD
Pentosan Polysulfate—Vomiting—Telmisartan—coronary artery disease	7.55e-05	0.000493	CcSEcCtD
Pentosan Polysulfate—Headache—Enalapril—coronary artery disease	7.54e-05	0.000492	CcSEcCtD
Pentosan Polysulfate—Nausea—Niacin—coronary artery disease	7.51e-05	0.00049	CcSEcCtD
Pentosan Polysulfate—Rash—Telmisartan—coronary artery disease	7.49e-05	0.000489	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Telmisartan—coronary artery disease	7.48e-05	0.000488	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Furosemide—coronary artery disease	7.46e-05	0.000487	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.45e-05	0.000486	CcSEcCtD
Pentosan Polysulfate—Pruritus—Losartan—coronary artery disease	7.44e-05	0.000486	CcSEcCtD
Pentosan Polysulfate—Headache—Telmisartan—coronary artery disease	7.44e-05	0.000486	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Ramipril—coronary artery disease	7.43e-05	0.000485	CcSEcCtD
Pentosan Polysulfate—Dizziness—Perindopril—coronary artery disease	7.41e-05	0.000484	CcSEcCtD
Pentosan Polysulfate—Insomnia—Lisinopril—coronary artery disease	7.4e-05	0.000483	CcSEcCtD
Pentosan Polysulfate—Nausea—Pravastatin—coronary artery disease	7.39e-05	0.000483	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Ramipril—coronary artery disease	7.37e-05	0.000481	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Lisinopril—coronary artery disease	7.34e-05	0.000479	CcSEcCtD
Pentosan Polysulfate—Vomiting—Captopril—coronary artery disease	7.34e-05	0.000479	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Lisinopril—coronary artery disease	7.29e-05	0.000476	CcSEcCtD
Pentosan Polysulfate—Rash—Captopril—coronary artery disease	7.28e-05	0.000475	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Captopril—coronary artery disease	7.27e-05	0.000475	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Timolol—coronary artery disease	7.26e-05	0.000474	CcSEcCtD
Pentosan Polysulfate—Headache—Captopril—coronary artery disease	7.23e-05	0.000472	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Timolol—coronary artery disease	7.21e-05	0.000471	CcSEcCtD
Pentosan Polysulfate—Dizziness—Furosemide—coronary artery disease	7.21e-05	0.000471	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Lisinopril—coronary artery disease	7.2e-05	0.00047	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Losartan—coronary artery disease	7.2e-05	0.00047	CcSEcCtD
Pentosan Polysulfate—Nausea—Trandolapril—coronary artery disease	7.18e-05	0.000469	CcSEcCtD
Pentosan Polysulfate—Urticaria—Ramipril—coronary artery disease	7.16e-05	0.000468	CcSEcCtD
Pentosan Polysulfate—Nausea—Enalapril—coronary artery disease	7.15e-05	0.000467	CcSEcCtD
Pentosan Polysulfate—Vomiting—Perindopril—coronary artery disease	7.13e-05	0.000465	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Ramipril—coronary artery disease	7.13e-05	0.000465	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Lisinopril—coronary artery disease	7.11e-05	0.000464	CcSEcCtD
Pentosan Polysulfate—Rash—Perindopril—coronary artery disease	7.07e-05	0.000462	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Perindopril—coronary artery disease	7.06e-05	0.000461	CcSEcCtD
Pentosan Polysulfate—Nausea—Telmisartan—coronary artery disease	7.05e-05	0.00046	CcSEcCtD
Pentosan Polysulfate—Headache—Perindopril—coronary artery disease	7.02e-05	0.000459	CcSEcCtD
Pentosan Polysulfate—Urticaria—Timolol—coronary artery disease	7e-05	0.000457	CcSEcCtD
Pentosan Polysulfate—Constipation—Lisinopril—coronary artery disease	6.99e-05	0.000457	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Timolol—coronary artery disease	6.97e-05	0.000455	CcSEcCtD
Pentosan Polysulfate—Dizziness—Losartan—coronary artery disease	6.95e-05	0.000454	CcSEcCtD
Pentosan Polysulfate—Vomiting—Furosemide—coronary artery disease	6.93e-05	0.000452	CcSEcCtD
Pentosan Polysulfate—Rash—Furosemide—coronary artery disease	6.87e-05	0.000449	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Furosemide—coronary artery disease	6.87e-05	0.000448	CcSEcCtD
Pentosan Polysulfate—Nausea—Captopril—coronary artery disease	6.86e-05	0.000448	CcSEcCtD
Pentosan Polysulfate—Headache—Furosemide—coronary artery disease	6.83e-05	0.000446	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Lisinopril—coronary artery disease	6.74e-05	0.00044	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Lisinopril—coronary artery disease	6.69e-05	0.000437	CcSEcCtD
Pentosan Polysulfate—Vomiting—Losartan—coronary artery disease	6.69e-05	0.000437	CcSEcCtD
Pentosan Polysulfate—Nausea—Perindopril—coronary artery disease	6.66e-05	0.000435	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Ramipril—coronary artery disease	6.64e-05	0.000434	CcSEcCtD
Pentosan Polysulfate—Rash—Losartan—coronary artery disease	6.63e-05	0.000433	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Losartan—coronary artery disease	6.62e-05	0.000432	CcSEcCtD
Pentosan Polysulfate—Headache—Losartan—coronary artery disease	6.59e-05	0.00043	CcSEcCtD
Pentosan Polysulfate—Urticaria—Lisinopril—coronary artery disease	6.5e-05	0.000424	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Timolol—coronary artery disease	6.49e-05	0.000424	CcSEcCtD
Pentosan Polysulfate—Nausea—Furosemide—coronary artery disease	6.47e-05	0.000423	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Lisinopril—coronary artery disease	6.46e-05	0.000422	CcSEcCtD
Pentosan Polysulfate—Pruritus—Ramipril—coronary artery disease	6.38e-05	0.000416	CcSEcCtD
Pentosan Polysulfate—Nausea—Losartan—coronary artery disease	6.25e-05	0.000408	CcSEcCtD
Pentosan Polysulfate—Pruritus—Timolol—coronary artery disease	6.24e-05	0.000407	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Ramipril—coronary artery disease	6.17e-05	0.000403	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Timolol—coronary artery disease	6.03e-05	0.000394	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Lisinopril—coronary artery disease	6.03e-05	0.000393	CcSEcCtD
Pentosan Polysulfate—Dizziness—Ramipril—coronary artery disease	5.96e-05	0.000389	CcSEcCtD
Pentosan Polysulfate—Dizziness—Timolol—coronary artery disease	5.83e-05	0.000381	CcSEcCtD
Pentosan Polysulfate—Pruritus—Lisinopril—coronary artery disease	5.79e-05	0.000378	CcSEcCtD
Pentosan Polysulfate—Vomiting—Ramipril—coronary artery disease	5.73e-05	0.000374	CcSEcCtD
Pentosan Polysulfate—Rash—Ramipril—coronary artery disease	5.69e-05	0.000371	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Ramipril—coronary artery disease	5.68e-05	0.000371	CcSEcCtD
Pentosan Polysulfate—Headache—Ramipril—coronary artery disease	5.65e-05	0.000369	CcSEcCtD
Pentosan Polysulfate—Vomiting—Timolol—coronary artery disease	5.6e-05	0.000366	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Lisinopril—coronary artery disease	5.6e-05	0.000365	CcSEcCtD
Pentosan Polysulfate—Rash—Timolol—coronary artery disease	5.56e-05	0.000363	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Timolol—coronary artery disease	5.55e-05	0.000363	CcSEcCtD
Pentosan Polysulfate—Headache—Timolol—coronary artery disease	5.52e-05	0.000361	CcSEcCtD
Pentosan Polysulfate—Dizziness—Lisinopril—coronary artery disease	5.41e-05	0.000353	CcSEcCtD
Pentosan Polysulfate—Nausea—Ramipril—coronary artery disease	5.36e-05	0.00035	CcSEcCtD
Pentosan Polysulfate—Nausea—Timolol—coronary artery disease	5.24e-05	0.000342	CcSEcCtD
Pentosan Polysulfate—Vomiting—Lisinopril—coronary artery disease	5.2e-05	0.000339	CcSEcCtD
Pentosan Polysulfate—Rash—Lisinopril—coronary artery disease	5.16e-05	0.000337	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Lisinopril—coronary artery disease	5.15e-05	0.000336	CcSEcCtD
Pentosan Polysulfate—Headache—Lisinopril—coronary artery disease	5.12e-05	0.000334	CcSEcCtD
Pentosan Polysulfate—Nausea—Lisinopril—coronary artery disease	4.86e-05	0.000317	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—FN1—coronary artery disease	8.94e-06	5.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—F2—coronary artery disease	8.94e-06	5.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—coronary artery disease	8.9e-06	5.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6ST—coronary artery disease	8.9e-06	5.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NFKBIA—coronary artery disease	8.83e-06	5.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ITGAV—coronary artery disease	8.81e-06	5.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HIF1A—coronary artery disease	8.8e-06	5.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BDKRB2—coronary artery disease	8.8e-06	5.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL12—coronary artery disease	8.8e-06	5.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—coronary artery disease	8.8e-06	5.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KNG1—coronary artery disease	8.78e-06	5.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PPP2CA—coronary artery disease	8.77e-06	5.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6ST—coronary artery disease	8.74e-06	5.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ICAM1—coronary artery disease	8.74e-06	5.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AGTR1—coronary artery disease	8.73e-06	5.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2L1—coronary artery disease	8.73e-06	5.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NFKBIA—coronary artery disease	8.67e-06	5.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CRP—coronary artery disease	8.67e-06	5.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—coronary artery disease	8.67e-06	5.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUNB—coronary artery disease	8.64e-06	5.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PRKCD—coronary artery disease	8.61e-06	5.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLCB1—coronary artery disease	8.61e-06	5.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOE—coronary artery disease	8.59e-06	5.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KIT—coronary artery disease	8.55e-06	5.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL10—coronary artery disease	8.53e-06	5.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PLG—coronary artery disease	8.5e-06	5.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOA1—coronary artery disease	8.49e-06	5.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HTR7—coronary artery disease	8.43e-06	5.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTHFR—coronary artery disease	8.42e-06	5.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KIT—coronary artery disease	8.4e-06	5.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—coronary artery disease	8.32e-06	5.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ADRB2—coronary artery disease	8.28e-06	5.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK14—coronary artery disease	8.26e-06	5.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—GSK3B—coronary artery disease	8.21e-06	5.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PRKCE—coronary artery disease	8.17e-06	5.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TGFB1—coronary artery disease	8.17e-06	5.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SOCS1—coronary artery disease	8.15e-06	5.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—POMC—coronary artery disease	8.14e-06	5.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CREB1—coronary artery disease	8.14e-06	5.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—S100B—coronary artery disease	8.13e-06	5.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6ST—coronary artery disease	8.07e-06	5.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—GSK3B—coronary artery disease	8.06e-06	5.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SOCS3—coronary artery disease	8.05e-06	5.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ITGAV—coronary artery disease	8.03e-06	5.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HIF1A—coronary artery disease	8.03e-06	5.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MAPK1—coronary artery disease	8.02e-06	5.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS2—coronary artery disease	8.01e-06	5.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KNG1—coronary artery disease	8.01e-06	5.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CREB1—coronary artery disease	7.99e-06	5.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ICAM1—coronary artery disease	7.97e-06	5.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6ST—coronary artery disease	7.97e-06	5.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL2—coronary artery disease	7.97e-06	5.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFBR2—coronary artery disease	7.96e-06	5.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KITLG—coronary artery disease	7.96e-06	5.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AGTR1—coronary artery disease	7.96e-06	5.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6R—coronary artery disease	7.94e-06	5.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NFKBIA—coronary artery disease	7.91e-06	5.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOE—coronary artery disease	7.84e-06	4.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF1—coronary artery disease	7.83e-06	4.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6R—coronary artery disease	7.8e-06	4.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP3—coronary artery disease	7.78e-06	4.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT5A—coronary artery disease	7.78e-06	4.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL10—coronary artery disease	7.78e-06	4.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MAPK1—coronary artery disease	7.76e-06	4.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLG—coronary artery disease	7.76e-06	4.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KIT—coronary artery disease	7.75e-06	4.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOA1—coronary artery disease	7.75e-06	4.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KIT—coronary artery disease	7.66e-06	4.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—coronary artery disease	7.63e-06	4.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADRB2—coronary artery disease	7.55e-06	4.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOB—coronary artery disease	7.52e-06	4.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PRKCE—coronary artery disease	7.45e-06	4.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—GSK3B—coronary artery disease	7.44e-06	4.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SERPINE1—coronary artery disease	7.44e-06	4.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SOCS1—coronary artery disease	7.44e-06	4.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—S100B—coronary artery disease	7.42e-06	4.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EDN1—coronary artery disease	7.4e-06	4.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CREB1—coronary artery disease	7.38e-06	4.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6ST—coronary artery disease	7.36e-06	4.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—GSK3B—coronary artery disease	7.35e-06	4.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SOCS3—coronary artery disease	7.34e-06	4.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL5—coronary artery disease	7.34e-06	4.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS2—coronary artery disease	7.3e-06	4.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CREB1—coronary artery disease	7.29e-06	4.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KITLG—coronary artery disease	7.26e-06	4.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFBR2—coronary artery disease	7.26e-06	4.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CSF2—coronary artery disease	7.23e-06	4.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FGF2—coronary artery disease	7.2e-06	4.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6R—coronary artery disease	7.2e-06	4.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LPL—coronary artery disease	7.18e-06	4.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MAPK1—coronary artery disease	7.12e-06	4.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RPS6KB1—coronary artery disease	7.11e-06	4.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MEF2C—coronary artery disease	7.11e-06	4.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6R—coronary artery disease	7.11e-06	4.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOS3—coronary artery disease	7.1e-06	4.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP3—coronary artery disease	7.09e-06	4.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT5A—coronary artery disease	7.09e-06	4.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MAPK1—coronary artery disease	7.08e-06	4.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KIT—coronary artery disease	7.07e-06	4.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FGF2—coronary artery disease	7.07e-06	4.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ITGB3—coronary artery disease	6.93e-06	4.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JAK2—coronary artery disease	6.9e-06	4.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOB—coronary artery disease	6.86e-06	4.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—GSK3B—coronary artery disease	6.79e-06	4.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JAK2—coronary artery disease	6.78e-06	4.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EDN1—coronary artery disease	6.75e-06	4.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SERPINE1—coronary artery disease	6.74e-06	4.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—coronary artery disease	6.74e-06	4.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PPP2CA—coronary artery disease	6.73e-06	4.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CREB1—coronary artery disease	6.73e-06	4.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2—coronary artery disease	6.71e-06	4.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TGFB1—coronary artery disease	6.71e-06	4.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL5—coronary artery disease	6.69e-06	4.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PRKCD—coronary artery disease	6.61e-06	4.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CSF2—coronary artery disease	6.59e-06	4.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGF1—coronary artery disease	6.59e-06	4.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MAPK1—coronary artery disease	6.58e-06	4.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6R—coronary artery disease	6.57e-06	4.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LPL—coronary artery disease	6.55e-06	4.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGF2—coronary artery disease	6.53e-06	4.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MEF2C—coronary artery disease	6.49e-06	4.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RPS6KB1—coronary artery disease	6.49e-06	4.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HTR2A—coronary artery disease	6.47e-06	4.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—coronary artery disease	6.47e-06	4.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—C3—coronary artery disease	6.46e-06	4.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS3—coronary artery disease	6.44e-06	4.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ITGB3—coronary artery disease	6.32e-06	4.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—coronary artery disease	6.3e-06	4.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—JAK2—coronary artery disease	6.26e-06	3.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—coronary artery disease	6.18e-06	3.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JAK2—coronary artery disease	6.18e-06	3.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—coronary artery disease	6.16e-06	3.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—coronary artery disease	6.16e-06	3.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SERPINE1—coronary artery disease	6.15e-06	3.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—coronary artery disease	6.14e-06	3.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PPP2CA—coronary artery disease	6.14e-06	3.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AGT—coronary artery disease	6.14e-06	3.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2—coronary artery disease	6.12e-06	3.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PRKCD—coronary artery disease	6.03e-06	3.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—coronary artery disease	6.03e-06	3.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LEP—coronary artery disease	6.02e-06	3.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOE—coronary artery disease	6.02e-06	3.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—coronary artery disease	5.96e-06	3.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOA1—coronary artery disease	5.95e-06	3.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL1B—coronary artery disease	5.93e-06	3.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HTR2A—coronary artery disease	5.9e-06	3.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—coronary artery disease	5.9e-06	3.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—coronary artery disease	5.89e-06	3.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—C3—coronary artery disease	5.89e-06	3.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—coronary artery disease	5.89e-06	3.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS3—coronary artery disease	5.87e-06	3.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—coronary artery disease	5.87e-06	3.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK14—coronary artery disease	5.86e-06	3.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ESR1—coronary artery disease	5.74e-06	3.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—coronary artery disease	5.71e-06	3.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—JAK2—coronary artery disease	5.71e-06	3.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—coronary artery disease	5.7e-06	3.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—coronary artery disease	5.68e-06	3.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FN1—coronary artery disease	5.67e-06	3.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—F2—coronary artery disease	5.67e-06	3.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6ST—coronary artery disease	5.65e-06	3.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—coronary artery disease	5.62e-06	3.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NFKBIA—coronary artery disease	5.61e-06	3.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AGT—coronary artery disease	5.6e-06	3.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—coronary artery disease	5.5e-06	3.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOE—coronary artery disease	5.49e-06	3.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LEP—coronary artery disease	5.49e-06	3.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—coronary artery disease	5.47e-06	3.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—coronary artery disease	5.44e-06	3.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—coronary artery disease	5.43e-06	3.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOA1—coronary artery disease	5.42e-06	3.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1B—coronary artery disease	5.41e-06	3.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—coronary artery disease	5.38e-06	3.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—coronary artery disease	5.37e-06	3.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK14—coronary artery disease	5.34e-06	3.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—coronary artery disease	5.28e-06	3.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ESR1—coronary artery disease	5.24e-06	3.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GSK3B—coronary artery disease	5.21e-06	3.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—F2—coronary artery disease	5.17e-06	3.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FN1—coronary artery disease	5.17e-06	3.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—POMC—coronary artery disease	5.17e-06	3.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CREB1—coronary artery disease	5.17e-06	3.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6ST—coronary artery disease	5.15e-06	3.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—coronary artery disease	5.12e-06	3.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NFKBIA—coronary artery disease	5.11e-06	3.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL2—coronary artery disease	5.06e-06	3.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—coronary artery disease	5.05e-06	3.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—coronary artery disease	5.05e-06	3.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6R—coronary artery disease	5.04e-06	3.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—coronary artery disease	5.02e-06	3.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1—coronary artery disease	4.97e-06	3.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—coronary artery disease	4.95e-06	3.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—coronary artery disease	4.82e-06	3.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GSK3B—coronary artery disease	4.75e-06	3.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SERPINE1—coronary artery disease	4.72e-06	3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—POMC—coronary artery disease	4.71e-06	3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CREB1—coronary artery disease	4.71e-06	3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—coronary artery disease	4.7e-06	2.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—coronary artery disease	4.66e-06	2.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL2—coronary artery disease	4.61e-06	2.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK1—coronary artery disease	4.61e-06	2.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6R—coronary artery disease	4.6e-06	2.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGF2—coronary artery disease	4.57e-06	2.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1—coronary artery disease	4.53e-06	2.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK1—coronary artery disease	4.52e-06	2.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOS3—coronary artery disease	4.51e-06	2.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JAK2—coronary artery disease	4.38e-06	2.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SERPINE1—coronary artery disease	4.31e-06	2.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—coronary artery disease	4.26e-06	2.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK1—coronary artery disease	4.17e-06	2.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK1—coronary artery disease	4.12e-06	2.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOS3—coronary artery disease	4.11e-06	2.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—coronary artery disease	4e-06	2.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—coronary artery disease	4e-06	2.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JAK2—coronary artery disease	4e-06	2.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—coronary artery disease	3.92e-06	2.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—coronary artery disease	3.88e-06	2.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—coronary artery disease	3.83e-06	2.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK1—coronary artery disease	3.81e-06	2.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—coronary artery disease	3.73e-06	2.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—coronary artery disease	3.65e-06	2.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—coronary artery disease	3.62e-06	2.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—coronary artery disease	3.62e-06	2.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—coronary artery disease	3.58e-06	2.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—coronary artery disease	3.54e-06	2.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—coronary artery disease	3.49e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—coronary artery disease	3.47e-06	2.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—coronary artery disease	3.4e-06	2.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—coronary artery disease	3.3e-06	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—coronary artery disease	3.3e-06	2.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—coronary artery disease	3.26e-06	2.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—coronary artery disease	3.25e-06	2.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—coronary artery disease	3.21e-06	2.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—coronary artery disease	3.2e-06	2.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—coronary artery disease	3.17e-06	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—coronary artery disease	2.98e-06	1.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—coronary artery disease	2.96e-06	1.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—coronary artery disease	2.96e-06	1.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—coronary artery disease	2.92e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK1—coronary artery disease	2.92e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—coronary artery disease	2.92e-06	1.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—coronary artery disease	2.72e-06	1.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—coronary artery disease	2.7e-06	1.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK1—coronary artery disease	2.67e-06	1.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—coronary artery disease	2.54e-06	1.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—coronary artery disease	2.31e-06	1.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—coronary artery disease	2.25e-06	1.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—coronary artery disease	2.07e-06	1.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—coronary artery disease	2.05e-06	1.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—coronary artery disease	1.89e-06	1.2e-05	CbGpPWpGaD
